Moore Capital Management’s Tenet Healthcare THC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$22M Buy
+117,693
New +$21.6M 0.33% 57
2025
Q2
Sell
-127,535
Closed -$17.2M 663
2025
Q1
$17.2M Buy
127,535
+72,507
+132% +$9.55M 0.35% 47
2024
Q4
$6.95M Buy
+55,028
New +$8.18M 0.08% 211
2024
Q1
Sell
-30,000
Closed -$2.27M 535
2023
Q4
$2.27M Buy
+30,000
New +$1.9M 0.04% 218
2023
Q2
Sell
-5,700
Closed -$339K 591
2023
Q1
$339K Buy
+5,700
New +$317K 0.01% 333
2016
Q1
Sell
-40,156
Closed -$1.22M 338
2015
Q4
$1.22M Buy
+40,156
New +$1.32M 0.04% 245
2015
Q3
Sell
-170,176
Closed -$9.85M 401
2015
Q2
$9.85M Buy
170,176
+142,752
+521% +$7.29M 0.21% 106
2015
Q1
$1.36M Buy
27,424
+5,425
+25% +$254K 0.03% 323
2014
Q4
$1.11M Sell
21,999
-140,452
-86% -$7.34M 0.04% 263
2014
Q3
$9.65M Buy
162,451
+7,610
+5% +$425K 0.23% 123
2014
Q2
$7.27M Buy
154,841
+145,853
+1,623% +$6.59M 0.18% 135
2014
Q1
$385K Buy
+8,988
New +$397K 0.01% 429

Other funds holding THC

Moore Capital Management's THC Position: Q2 2026 in Review

Moore Capital Management opened a new position in Tenet Healthcare (THC) in Q2 2026: 117,693 shares worth $22M. The stake represents 0.33% of the portfolio and ranks #57 among its holdings. This is a return to the name: Moore Capital Management previously reported a position in THC as recently as Q1 2025.

Moore Capital Management first reported a position in THC in Q1 2014 and has held it in 12 quarters since. 679 funds tracked by Wall St. Rank hold THC as of Q2 2026.

  • Moore Capital Management held 117,693 shares of Tenet Healthcare worth $22M as of Q2 2026.
  • Tenet Healthcare was a new Moore Capital Management position in Q2 2026.
  • Tenet Healthcare made up 0.33% of Moore Capital Management's portfolio in Q2 2026, its #57 holding.
  • Moore Capital Management first reported a position in Tenet Healthcare in Q1 2014 and has held it in 12 quarters since.
  • 679 funds tracked by Wall St. Rank held Tenet Healthcare as of Q2 2026.

Based on Moore Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.